Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma

Health-related quality of life was a secondary endpoint in the phase III GALLIUM study in previously untreated patients with follicular lymphoma who were treated with rituximab- or obinutuzumab-chemotherapy. Patients were randomized 1:1 to receive induction therapy with obinutuzumab- or rituximab-ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hematol
Main Authors: Davies, Andrew, Trask, Peter, Demeter, Judit, Florschütz, Axel, Hänel, Mathias, Kinoshita, Tomohiro, Pettengell, Ruth, Quach, Hang, Robinson, Stephen, Sadullah, Shalal, Sancho, Juan-Manuel, Udvardy, Miklos, Witzens-Harig, Mathias, Knapp, Andrea, Liu, Wenxin
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683459/
https://ncbi.nlm.nih.gov/pubmed/32314038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04021-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados